Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Saved in:
| Title: | Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. |
|---|---|
| Authors: | Koole S; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Stein R; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Sikorska K; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands., Barton D; Department of Gynaecological Oncology, Royal Marsden Hospital NHS Trust, London, UK., Perrin L; Queensland Centre for Gynaecological Cancer, Herston, Queensland, Australia., Brennan D; Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland., Zivanovic O; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mosgaard BJ; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark., Fagotti A; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Colombo PE; Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France., Sonke G; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Driel WJV; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands w.v.driel@nki.nl.; Center for Gynaecologic Oncology Amsterdam, Center for Gynaecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Dutch Gynecological Oncology Group (DGOG), the Netherlands, the Netherlands.; Dutch Peritoneal Oncology Group (DPOG), the Netherlands, the Netherlands. |
| Corporate Authors: | OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group |
| Source: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Jun; Vol. 30 (6), pp. 888-892. Date of Electronic Publication: 2020 Mar 23. |
| Publication Type: | Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
